FAR1: A Promising Drug Target for Cancer and Other Diseases (G84188)

Target Name: FAR1

NCBI ID: G84188

FAR1

FAR1: A Promising Drug Target for Cancer and Other Diseases

FAR1 (fusions of A to T) is a gene that encodes a protein known as FAR1. FAR1 is a protein that is expressed in many different tissues throughout the body, including the lungs, heart, kidneys, and brain. It is a key regulator of cell growth and division, and is involved in the development and maintenance of many different tissues.

One of the things that makes FAR1 so interesting as a drug target is its role in the regulation of cell proliferation. In fact, FAR1 is highly expressed in cancer cells, and has been shown to be involved in the development and progression of many different types of cancer. This makes it an attractive target for cancer treatments, as it can be used to inhibit the growth and spread of cancer cells.

Another way that FAR1 has been identified as a potential drug target is its role in the regulation of cell death. FAR1 is involved in the process of cell apoptosis, which is a natural and regulated way for cells to die. However, in some diseases, cells do not undergo apoptosis, and this can lead to the build-up of dangerous amounts of cells that can cause problems. By inhibiting FAR1, researchers have found that they can encourage cells to undergo apoptosis, which can be a useful way to treat many different types of diseases.

In addition to its role in cell proliferation and apoptosis, FAR1 has also been identified as a potential biomarker. This is because its expression is often increased in response to certain diseases or conditions, such as cancer. By detecting the expression of FAR1 in body tissues, researchers can potentially use it as a diagnostic or predictive tool for many different types of diseases.

Overall, FAR1 is a gene that has a great deal of potential as a drug target. Its involvement in the regulation of cell growth and division, as well as its role in cell apoptosis, makes it an attractive target for cancer treatments. Additionally, its potential as a biomarker for many different types of diseases also makes it an important tool for researchers to study.

Protein Name: Fatty Acyl-CoA Reductase 1

Functions: Catalyzes the reduction of saturated and unsaturated C16 or C18 fatty acyl-CoA to fatty alcohols (PubMed:15220348, PubMed:24108123). It plays an essential role in the production of ether lipids/plasmalogens which synthesis requires fatty alcohols (PubMed:20071337, PubMed:24108123, PubMed:33239752). In parallel, it is also required for wax monoesters production since fatty alcohols also constitute a substrate for their synthesis (By similarity)

The "FAR1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAR1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets